Skip to main content
OpenTrials
Completed

NCT Number: NCT01390168

Internet-administrated Treatment of Anxiety Disorders

The purpose of this study is to determine whether tailored internet-administered cbt is a feasible treatment for anxiety disorders in clinical settings.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anxiety Disorders Behavior Behavioral Symptoms Depression Mental Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Behavioural Sciences and Learning, Linköping University

Linköping, Östergötland County, 581 83, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • over 18 years
  • fulfill the criteria for at least one anxiety syndrome

Exclusion criteria

  • ongoing psychological treatment
  • suicidal prone
  • ongoing alcohol addiction

Treatment and study plan

Tailored Internet-administrated CBT-Treatment

Behavioral

This intervention contains up to 6-10 text-based self-help modules in which 4 modules are fixed (the first three and the last) and the rest are "prescribed following the diagnostic telephone interview. These modules contain material on panic disorder, social phobia, stress management, assertiveness training, concentration, relaxation among other things.

Waitlist

Behavioral

active waitlist

Primary outcomes

  1. Change from baseline in Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)

    Time frame: Two weeks pre treatment (baseline), two weeks post treatment, and 12 months post treatment

    Measures anxiety and depressive symptoms.

    Change from baseline in anxiety and depressive symptoms expected between time frames.

Secondary outcomes

  1. Change from baseline in Beck Anxiety Inventory (BAI)

    Time frame: Two weeks pre treatment (baseline), two weeks post treatment, 12 months post treatment

    Measures anxiety symtoms.

    Change from baseline in anxiety symptoms expected between time frames.

  2. Change from baseline in Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S)

    Time frame: Two weeks pre treatment (baseline), two weeks post treatment, and 12 months post treatment

    Measures depressive symptoms.

    Change from baseline in depressive symptoms expected between time frames.

  3. Change from baseline in Quality of Life Inventory (QOLI)

    Time frame: Two weeks pre treatment (baseline), two weeks post treatment, and 12 months post treatment

    Measures quality of life.

    Change from baseline in quality of life expected between time frames.

Sponsors and collaborators

Lead sponsor

Umeå University

Other

Registry information

Official study title

Tailored Internet-administrated Treatment of Anxiety Disorders - A Randomised Controlled Trial (NOVA II)

Acronym: NOVA II

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Jul 8, 2011
Registry last updated
Mar 5, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.